These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 9567749

  • 1. Status of urea and related enzymes during Plasmodium yoelii infection and pyrimethamine treatment in mice.
    Agrawal A, Tripathi LM, Pandey VC.
    Indian J Exp Biol; 1997 Nov; 35(11):1194-7. PubMed ID: 9567749
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Status of ammonia, glutamate, lactate and pyruvate during Plasmodium yoelii infection and pyrimethamine treatment in mice.
    Agarwal A, Tripathi LM, Pandey VC.
    J Commun Dis; 1997 Sep; 29(3):235-41. PubMed ID: 9465528
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Studies on drug metabolizing enzymes during arteether treatment of Plasmodium yoelii nigeriensis infected mice cerebral microvessels.
    Agrawal A.
    J Commun Dis; 2005 Mar; 37(1):44-50. PubMed ID: 16637400
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Plasmodium yoelii: activity of azithromycin in combination with pyrimethamine or sulfadoxine against blood and sporozoite induced infections in Swiss mice.
    Neerja J, Puri SK.
    Exp Parasitol; 2004 Mar; 107(3-4):120-4. PubMed ID: 15363937
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Within-host selection of drug resistance in a mouse model of repeated interrupted treatment of Plasmodium yoelii infection.
    Nuralitha S, Siregar JE, Syafruddin D, Hoepelman AIM, Marzuki S.
    Malar J; 2017 May 23; 16(1):216. PubMed ID: 28535797
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Early treatment during a primary malaria infection modifies the development of cross immunity.
    Legorreta-Herrera M, Ventura-Ayala ML, Licona-Chávez RN, Soto-Cruz I, Hernández-Clemente FF.
    Parasite Immunol; 2004 Jan 23; 26(1):7-17. PubMed ID: 15198641
    [Abstract] [Full Text] [Related]

  • 14. Antimalarial properties of Goniothalamin in combination with chloroquine against Plasmodium yoelii and Plasmodium berghei growth in mice.
    Mohd Ridzuan MA, Ruenruetai U, Noor Rain A, Khozirah S, Zakiah I.
    Trop Biomed; 2006 Dec 23; 23(2):140-6. PubMed ID: 17322815
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Studies on erythrocytic methemoglobin reductase systems in Plasmodium yoelii nigeriensis infected mice.
    Srivastava S, Alhomida AS, Siddiqi NJ.
    In Vivo; 2000 Dec 23; 14(4):547-50. PubMed ID: 10945172
    [Abstract] [Full Text] [Related]

  • 18. Immunomodulatory role of chloroquine and pyrimethamine in Plasmodium yoelii 17XL infected mice.
    Ramos-Avila A, Ventura-Gallegos JL, Zentella-Dehesa A, Machuca-Rodríguez C, Moreno-Altamirano MM, Narváez V, Legorreta-Herrera M.
    Scand J Immunol; 2007 Jan 23; 65(1):54-62. PubMed ID: 17212767
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.